Chronic headache is defined as head pain occurring on 15 or more days per month for at least three months, and it affects a significant minority of the general population, with estimates typically placing prevalence between 3 and 5 percent of adults. The term itself is an umbrella: it covers chronic migraine, chronic tension-type headache, new daily persistent headache, and hemicrania continua, each with distinct features but sharing the burden of near-constant or very frequent pain.1PubMed. Chronic migraine, classification, differential diagnosis, and epidemiology What makes chronic headache particularly frustrating is that the line between “bad headaches” and a chronic headache disorder is not just about frequency. Crossing that threshold involves real changes in how the brain processes pain, and understanding those changes is the key to both prevention and treatment.
The 15-Day Threshold and What Falls Under It
The 15-days-per-month criterion may seem arbitrary, but it marks a clinically meaningful boundary. Below that frequency, headaches are classified as episodic. Above it, the disorder qualifies as chronic daily headache of long duration, a syndrome that encompasses four primary types. Chronic migraine is the most disabling of the four, requiring that attacks last four or more hours on average.2PubMed. Chronic migraine, classification, differential diagnosis, and epidemiology Chronic tension-type headache tends to produce a pressing, band-like pain on both sides of the head without the nausea or light sensitivity typical of migraine. New daily persistent headache begins abruptly in someone without a significant headache history and simply does not stop. Hemicrania continua produces continuous one-sided pain that fluctuates in severity.
Diagnosing any of these requires ruling out secondary causes first, such as a mass, infection, or vascular problem, then matching the headache’s features to one of these primary syndromes based on duration, frequency, and accompanying symptoms. In practice, the boundaries between chronic migraine and chronic tension-type headache can blur, especially when someone has had frequent headaches for a long time. Research using statistical methods to test whether migraine and tension-type headache are truly separate categories or points on a continuum found that the answer depends on who you study: in people with high headache frequency (15 or more days per month) and younger adults, headaches looked more like a single spectrum, while in people with less frequent headaches and those over 24, the two types looked like genuinely distinct conditions.3PubMed Central. Are Migraine and Tension-Type Headache Diagnostic Types or Points on a Severity Continuum?: An Exploration of the Latent Taxometric Structure of Headache That finding matters because it suggests that the more chronic your headaches become, the less cleanly they fit into neat diagnostic boxes.
Still, when clinicians look beyond the headache itself and consider the patient’s full history, chronic migraine and chronic tension-type headache do emerge as different clinical entities.4PubMed. Chronic migraine and chronic tension-type headache: are they the same or different? The distinction matters for treatment, because the medications and strategies that help one may not help the other.
How Headaches Become Chronic
Most people with chronic headache did not start out that way. The typical trajectory is a gradual increase in headache frequency over months or years, a process clinicians call chronification. At the biological level, the central mechanism is sensitization: the brain’s pain-processing circuits become progressively more excitable, so stimuli that would not normally produce pain begin to do so, and pain signals that should fade are instead amplified.
In migraine, this process begins in the trigeminovascular system, a network of nerve fibers that surrounds blood vessels in the brain’s protective membranes. When these fibers are activated, they release signaling molecules, most prominently calcitonin gene-related peptide (CGRP), that promote inflammation and dilate blood vessels, producing the throbbing pain characteristic of a migraine attack.5PubMed Central. Understanding migraine: Potential role of neurogenic inflammation Preclinical models have confirmed that this neurogenic inflammation occurs at multiple points in the trigeminovascular system, from the outermost membranes surrounding the brain down to central pain-processing structures in the brainstem.6PubMed. The putative role of neuroinflammation in the complex pathophysiology of migraine: From bench to bedside
With repeated attacks, the initial peripheral sensitization gives way to central sensitization: the neurons in the brainstem and higher brain regions that relay pain signals become hyperexcitable even between attacks. In chronic migraine patients, brain imaging has revealed structural and functional changes in regions involved in pain modulation, suggesting the brain’s ability to turn down its own pain signals has become impaired.7PubMed Central. Chronic migraine: A process of dysmodulation and sensitization A similar process occurs in chronic tension-type headache, where prolonged muscle pain overwhelms the brain’s inhibitory mechanisms. High-density brain mapping has shown that people with chronic tension-type headache fail to dampen incoming pain signals the way healthy controls do, providing some of the first direct evidence that supraspinal pain processing is abnormal in these patients.8PubMed. Abnormal pain processing in chronic tension-type headache: a high-density EEG brain mapping study
Central sensitization shows up clinically as allodynia, which is pain from things that should not hurt, like combing your hair, wearing glasses, or resting your head on a pillow during an attack. If you have noticed this kind of sensitivity spreading over time, it may be a sign that your headache disorder is evolving toward a more chronic pattern.9PubMed Central. Central Sensitization in Migraine: A Narrative Review
The Medication Overuse Trap
One of the most common and least understood drivers of chronic headache is the very medication people take to treat it. Medication overuse headache develops when acute pain relievers, whether over-the-counter analgesics, triptans, or opioids, are used on too many days per month, typically ten or more for triptans and opioids, or 15 or more for simple analgesics. The headache itself then becomes self-perpetuating: the medication wears off, the headache returns, and the cycle deepens.
The mechanisms behind medication overuse headache are not fully worked out, but they involve changes at several levels. Animal and human studies point to sensitization of both peripheral and central pain pathways, neuronal hyperexcitability visible on brain imaging, and possible changes in the brainstem’s periaqueductal gray matter, a region critical for pain modulation.10PubMed Central. Preventing and treating medication overuse headache Other theories include disruption of the brain’s serotonin system from repeated medication exposure, with downstream effects on how the brain regulates pain.11PubMed. Medication overuse headache from antimigraine therapy: clinical features, pathogenesis and management Because migraine is the most common underlying condition, the interplay between migraine chronification and medication overuse makes this one of the more complicated scenarios clinicians face.
If you are using acute headache medication more than two or three days a week on a regular basis, the medication itself may be partly why your headaches are becoming more frequent. Withdrawal can be difficult, sometimes involving a temporary worsening of headaches for weeks, but it is often a prerequisite for any preventive treatment to work.
Stress, Hormones, and the Nervous System
Chronic stress is one of the most reliably reported headache triggers, and the relationship runs in both directions. Persistent stress drives changes in the hypothalamic-pituitary-adrenal (HPA) axis and the autonomic nervous system that promote neuroinflammation, increase pain sensitivity, and alter blood vessel tone, all of which lower the threshold for a headache to develop. But recurrent headaches themselves become a source of stress, creating a feedback loop in which headaches and stress reinforce each other.12PubMed Central. Chronic Stress and Headaches: The Role of the HPA Axis and Autonomic Nervous System
Hormonal fluctuations add another layer. Migraine is roughly two to three times more common in women than men after puberty, and the pattern closely tracks reproductive hormones. Migraine tends to appear after the first menstrual period, cluster around menstruation, and often improve during pregnancy and after menopause. The driving force appears to be estrogen fluctuation, particularly the drop in estrogen levels just before a period, which influences both neuronal excitability and blood vessel tone.13PubMed Central. Migraine in women: the role of hormones and their impact on vascular diseases Beyond hormones, there is also evidence for underlying genetic variance between the sexes in migraine susceptibility.14The Lancet Neurology. Sex differences in migraine
When the Neck Is the Problem
Not every chronic headache originates inside the skull. Cervicogenic headache is a secondary headache caused by problems in the neck, most often the upper cervical spine. The reason neck problems can produce head pain has to do with the convergence of cervical and trigeminal nerve signals in the brainstem. Pain signals from the upper neck feed into the same pool of neurons that processes pain from the face and head, so a problem at the level of the neck vertebrae, joints, or muscles can generate pain felt across the forehead, temples, and around the eyes.15PubMed Central. Understanding cervicogenic headache16PubMed. Convergence of cervical and trigeminal sensory afferents
Cervicogenic headache is classically one-sided, worsened by certain neck movements or sustained postures, and may be provoked by pressing on specific structures in the neck. It is commonly confused with migraine or tension-type headache, and the distinction matters because treatment is different: cervicogenic headache responds better to physical therapy, nerve blocks, and correcting postural issues than to standard migraine medications. If your chronic headache consistently starts at the back of your head and spreads forward, is always on the same side, and flares with neck movement, cervicogenic headache is worth investigating.
Dietary Triggers and the Gut Connection
Food-related triggers get enormous attention in headache circles, and the reality is complicated. A useful framing is that dietary factors are better understood as threshold modulators than as deterministic causes: in someone whose nervous system is already close to the threshold for an attack, a trigger like skipping a meal, becoming dehydrated, or consuming a specific food additive can push them over the edge, but the same trigger on a different day might do nothing.17Confinia Cephalalgica. To feed or to fast? Nutritional triggers in migraine: a narrative review Fasting and dehydration are among the most commonly reported dietary triggers. One randomized trial found that switching to a low-glycemic-index diet significantly reduced headache frequency and severity over three months compared to a medication-only control.18PubMed Central. The Role of Diet and Nutrition in Migraine Triggers and Treatment: A Systematic Literature Review
An emerging area of research connects the gut to headache through what is loosely called the gut-brain axis. Animal studies suggest that disruptions to gut bacteria can influence migraine-related pathways by increasing inflammation in the trigeminal system.19PubMed Central. Gut microbiota and migraine Human studies are at an early stage but have found associations between the composition of gut bacteria and headache frequency and severity. Changes in gut barrier function and the resulting low-grade inflammation could sustain the kind of trigeminovascular sensitization that underlies chronic migraine.20PubMed Central. Migraine and the Gut–Brain Axis—The Role of Microbiome-Targeted Biotics This research is still too preliminary to guide specific dietary or probiotic recommendations, but it offers a plausible biological explanation for why gut health and headache seem connected.
Genetics and the Migraine-Prone Brain
Chronic migraine runs in families, and the genetic picture is becoming clearer. Rare monogenic forms of migraine, such as familial hemiplegic migraine, are caused by mutations in genes that affect neurons, glial cells, or blood vessels, all of which increase the brain’s susceptibility to cortical spreading depression, the wave of electrical activity thought to underlie migraine aura. But these single-gene forms are uncommon. For the vast majority of people with migraine, the genetic architecture involves many common variants, each contributing only a small increase in risk. Genome-wide studies have now identified more than 180 such variants, and they cluster into networks affecting neuronal signaling and vascular function.21PubMed Central. Genetics of migraine: where are we now?
What this means practically is that migraine susceptibility is inherited but not deterministic. Having a parent with chronic migraine raises your odds, but environmental factors, lifestyle, and the headache-management decisions you make along the way all influence whether your headaches stay episodic or progress to chronic.
Treatments That Target the Pain Pathway Directly
The most significant development in chronic migraine treatment over the past decade has been the arrival of monoclonal antibodies that block CGRP, the signaling molecule at the center of trigeminovascular inflammation. Four antibodies are now available: erenumab, fremanezumab, galcanezumab, and eptinezumab, each given by injection or infusion on a monthly or quarterly schedule. A network meta-analysis of ten clinical trials found that galcanezumab at 120 mg produced the greatest reduction in mean monthly migraine days, while fremanezumab given quarterly had the best response rate, and eptinezumab was associated with the fewest side effects.22PubMed Central. Efficacy and Safety of Anti-CGRP Monoclonal Antibodies in Prevention of Chronic Migraine: A Bayesian Network Meta-analysis
Real-world follow-up data bear these findings out. In one Australian multicentre study, roughly half of patients achieved at least a 50 percent reduction in monthly headache days within the first three months, with a median reduction of ten headache days. About 58 percent continued treatment through twelve months, while roughly a quarter stopped because the medication was not effective enough and a smaller fraction stopped due to side effects or circumstance changes.23Journal of Headache and Pain. Twelve-month efficacy of CGRP monoclonal antibodies and predictive value of short-term response: results of an Australian multicentre study These antibodies do not cure chronic migraine, and they do not work for everyone, but for people who have failed two or more conventional preventive medications, they represent a genuinely different approach because they target the specific biology of the migraine pathway rather than borrowing drugs designed for other conditions.
Behavioral Approaches and Neuromodulation
Medication is only part of chronic headache management. Cognitive behavioral therapy has shown consistent benefits across both migraine and tension-type headache. Meta-analyses report significant reductions in headache frequency and migraine-related disability.24PubMed Central. Cognitive Behavioral Therapy for Migraine Headache: A Systematic Review and Meta-Analysis For chronic tension-type headache specifically, combining CBT with standard medication has been shown to be more effective at reducing headache frequency, intensity, and duration than medication alone.25European Psychiatry. P02-365 – The Effectiveness of Cognitive Behavioral Therapy on Reduction of Chronic Tension Headache Adding biofeedback training to CBT may further improve outcomes, with combined approaches producing larger and more sustained reductions in pain catastrophizing, sleep quality, and headache-related disability.26PubMed. Cognitive Behavioral Therapy and Biofeedback for Chronic Headache: Effects on Pain Catastrophizing, Sleep Quality, and Disability
For people who want a non-drug option or need to supplement what medication can do, several neuromodulation devices are now available. The Cefaly device, which stimulates branches of the trigeminal nerve through a patch on the forehead, was the first non-invasive neurostimulator approved for migraine. A handheld vagus nerve stimulator (gammaCore) is applied to the neck and has been cleared for both migraine and cluster headache. A systematic review of randomized trials found that non-invasive vagus nerve stimulation significantly reduced headache days in migraine patients, and certain device configurations increased the proportion of patients achieving at least a 50 percent reduction in attacks.27PubMed Central. Noninvasive vagus nerve stimulation for migraine: a systematic review and meta-analysis of randomized controlled trials Other devices include single-pulse transcranial magnetic stimulators and caloric vestibular stimulators, with more invasive options like occipital nerve stimulators reserved for the most treatment-resistant cases.28PubMed Central. Peripheral Neuromodulation for the Management of Headache None of these are miracle cures, but they expand the toolkit meaningfully, especially for patients who cannot tolerate medications or prefer to avoid them.
Chronic Headache in Children and Adolescents
Chronic daily headache is not only an adult problem. It affects up to about 4 percent of the pediatric population and can be profoundly disabling, contributing to missed school, social withdrawal, and family stress.29PubMed. Current perspectives on the development and treatment of chronic daily headache in children and adolescents The same subtypes occur in children: chronic migraine, chronic tension-type headache, and new daily persistent headache. But diagnosis is trickier because younger children struggle to describe their symptoms precisely, and pediatric headaches may present differently from adult versions. Historically, treatment recommendations for pediatric chronic headache were largely extrapolated from adult data. That has started to change, though options remain more limited, particularly regarding newer biologic therapies where pediatric trial data is still emerging. As in adults, a combination of medication, behavioral strategies, sleep hygiene, and lifestyle adjustments tends to produce the best outcomes, with particular attention to school attendance and social functioning.
Weather, Environment, and the Sensitivity of the Migraine Brain
People with chronic headache frequently report that weather changes trigger attacks, and they are not imagining it. A study examining atmospheric pressure fluctuations found that small decreases of about 6 to 10 hectopascals relative to standard atmospheric pressure most frequently triggered migraine attacks.30PubMed Central. Examination of fluctuations in atmospheric pressure related to migraine The migraine-prone brain also shows consistent differences in how it handles everyday sensory input. Functional MRI studies have demonstrated that between attacks, people with migraine show atypical brain responses to visual, olfactory, and skin stimulation, along with an absence of the normal habituation response, meaning their brain fails to “tune out” repeated stimuli the way it should.31PubMed Central. Functional MRI of migraine
This abnormal sensory processing helps explain why so many everyday stimuli, bright lights, strong smells, loud sounds, weather shifts, can act as triggers. The migraine brain is not simply overreacting to these inputs; it is processing them differently at a fundamental level, and chronic headache patients typically experience this heightened sensitivity more intensely and more persistently than those with occasional attacks.
An Evolutionary Puzzle
Given how disabling migraine can be, a natural question is why evolution has not weeded it out. Migraine susceptibility is heavily influenced by genetics, so it has been subject to natural selection for a very long time, and the condition’s prevalence may even be increasing. Several evolutionary hypotheses have been proposed to explain its persistence, including that it functions as a defense mechanism, that it represents a trade-off between genetic costs and benefits, or that a migraine-prone nervous system might confer some survival or reproductive advantage in other contexts.32PubMed. What is the evolutionary advantage of migraine?
One influential idea frames migraine as the inappropriate activation of an otherwise useful allostatic response. The severe pain, nausea, light avoidance, and desire to withdraw and rest during a migraine attack look remarkably like sickness behavior, an evolutionarily conserved response whose purpose is to force the organism to disengage from activity and redirect energy toward recovery and immune defense.33PubMed. Pain as an evolutionary necessity More recent work has extended this idea, proposing that migraine attacks represent the brain’s attempt to restore energy homeostasis when metabolic demands outstrip supply, with the trigeminovascular system acting as the executor of a forced-rest program.34PubMed. The evolutionary meaning of migraine In this view, the migraine-prone brain is not broken; it is equipped with an overly sensitive alarm system that was adaptive in ancestral environments but misfires under the metabolic and sensory demands of modern life.